Cargando…
Unexpected Mutations in HIV-1 That Confer Resistance to the Tat Inhibitor Didehydro-Cortistatin A
Didehydro-cortistatin A (dCA) is a human immunodeficiency virus type 1 (HIV-1) Tat inhibitor that functions by selectively binding to the RNA binding domain of Tat. In addition to inhibiting viral replication, dCA can drive HIV-1 into a state of “deep latency” in which latent viruses are refractory...
Autor principal: | Rice, Andrew P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6747727/ https://www.ncbi.nlm.nih.gov/pubmed/31289189 http://dx.doi.org/10.1128/mBio.01547-19 |
Ejemplares similares
-
Resistance to the Tat Inhibitor Didehydro-Cortistatin A Is Mediated by Heightened Basal HIV-1 Transcription
por: Mousseau, Guillaume, et al.
Publicado: (2019) -
The Tat Inhibitor Didehydro-Cortistatin A Prevents HIV-1 Reactivation from Latency
por: Mousseau, Guillaume, et al.
Publicado: (2015) -
Didehydro-Cortistatin A Inhibits HIV-1 by Specifically Binding to the Unstructured Basic Region of Tat
por: Mediouni, Sonia, et al.
Publicado: (2019) -
Tat inhibition by didehydro-Cortistatin A promotes heterochromatin formation at the HIV-1 long terminal repeat
por: Li, Chuan, et al.
Publicado: (2019) -
Synthesis of (+)-Cortistatin A
por: Shenvi, Ryan A., et al.
Publicado: (2008)